Interferon maintenance for prevention of relapse in favorable risk AML?

Sara H. Small; Jessica K. Altman; Leonidas C. Platanias

doi:10.1080/10428194.2021.1966790

Interferon maintenance for prevention of relapse in favorable risk AML?

Sara H. Small^*, Jessica K. Altman, Leonidas C. Platanias

^*Corresponding author for this work

Medicine, Hematology Oncology Division

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	2818-2819
Number of pages	2
Journal	Leukemia and Lymphoma
Volume	62
Issue number	12
DOIs	https://doi.org/10.1080/10428194.2021.1966790
State	Published - 2021

ASJC Scopus subject areas

Hematology
Oncology
Cancer Research

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1080/10428194.2021.1966790

Cite this

@article{27e6dd27e09344c8afa3aa1abe1754a9,

title = "Interferon maintenance for prevention of relapse in favorable risk AML?",

author = "Small, {Sara H.} and Altman, {Jessica K.} and Platanias, {Leonidas C.}",

year = "2021",

doi = "10.1080/10428194.2021.1966790",

language = "English (US)",

volume = "62",

pages = "2818--2819",

journal = "Leukemia and Lymphoma",

issn = "1042-8194",